These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 16229907

  • 1. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
    Gunduz Z, Dursun N, Akgun H, Ozturk F, Okur H, Koc N.
    Regul Pept; 2005 Dec 15; 132(1-3):59-66. PubMed ID: 16229907
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
    Rosón MI, Della Penna SL, Cao G, Gorzalczany S, Pandolfo M, Toblli JE, Fernández BE.
    J Cell Physiol; 2010 Jul 15; 224(1):41-8. PubMed ID: 20232302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G.
    Am J Kidney Dis; 1998 Mar 15; 31(3):453-63. PubMed ID: 9506682
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 15; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 10. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G, Liu KL, Chapuis B, Lo M.
    Am J Hypertens; 2005 May 15; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [Abstract] [Full Text] [Related]

  • 11. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
    Agarwal R, Siva S, Dunn SR, Sharma K.
    Am J Kidney Dis; 2002 Mar 15; 39(3):486-92. PubMed ID: 11877567
    [Abstract] [Full Text] [Related]

  • 12. Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy.
    Mas VR, Alvarellos T, Maluf DG, Ferreira-Gonzalez A, Oliveros L, Maldonado RA, de Boccardo G.
    Transpl Int; 2004 Oct 15; 17(9):540-4. PubMed ID: 15349718
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V, Wangensteen R, Sainz J, Duarte J, O'Valle F, Osuna A, Vargas F.
    Clin Sci (Lond); 2004 Mar 15; 106(3):251-9. PubMed ID: 14521506
    [Abstract] [Full Text] [Related]

  • 14. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R, Bonhomme MC, Diebold S.
    J Hypertens; 1996 Jan 15; 14(1):81-9. PubMed ID: 12013499
    [Abstract] [Full Text] [Related]

  • 15. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR, Lopes KL, Carillo BA, Bergamaschi CT, Carmona AK, Casarini DE, Furukawa L, Heimann JC, Campos RR, Dolnikoff MS.
    Am J Hypertens; 2007 Jun 15; 20(6):692-8. PubMed ID: 17531930
    [Abstract] [Full Text] [Related]

  • 16. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.
    Hypertens Res; 2011 Apr 15; 34(4):521-9. PubMed ID: 21270815
    [Abstract] [Full Text] [Related]

  • 17. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Apr 15; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 18. Renin angiotensin system blockade ameliorates lead nephropathy.
    Ng HY, Tain YL, Lee YT, Hsu CY, Chiou TT, Huang PC, Lee CT.
    Biochem Biophys Res Commun; 2013 Aug 23; 438(2):359-63. PubMed ID: 23896603
    [Abstract] [Full Text] [Related]

  • 19. [Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
    Wu W, Ding HL, Chen LH, Fu ZZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec 23; 26(12):1742-4. PubMed ID: 17259110
    [Abstract] [Full Text] [Related]

  • 20. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Auton Neurosci; 2003 Mar 28; 104(2):88-94. PubMed ID: 12648610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.